Naresh Bumma

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients”.

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients

Frontiers in Oncology(2021)10.3389/fonc.2020.575168

N/A

0DataRank · unranked

17 citations

Ying Huang, Nita Williams, Naresh Bumma, Abdullah Khan, Maria Chaudhry +5 more

Multidisciplinary amyloidosis care in the era of personalized medicine

Frontiers in Neurology(2022)10.3389/fneur.2022.935936

N/A

0DataRank · unranked

14 citations

Rami Kahwash, Samir V. Parikh, Michael Isfort, Miriam Freimer, Ajay Vallakati +6 more

Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy

Frontiers in Cardiovascular Medicine(2022)10.3389/fcvm.2022.907597

N/A

0DataRank · unranked

7 citations

Carlos Bermúdez, Cyril Ayuk Mbeng Takem Baiyee, Brandon Rodgers, Samir M. Parikh, Salem Almaani +10 more

Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias

Frontiers in Oncology(2022)10.3389/fonc.2022.858426

N/A

0DataRank · unranked

3 citations

Eric McLaughlin, Miguel Ruiz, Lai Wei, Naresh Bumma, Don Benson +17 more